Keratoconus Treatment Site

DO YOU HAVE KERATOCONUS?

Welcome to Dr. Brian, Keratoconus Specialist and highly sought after eye surgeon who PIONEERED the use of Intacs and Holcomb C3-R® treatments for Keratoconus
Read More
Keratoconus Treatment Site

Focus on your happiness

Intacs® reshape the curvature of the cornea from within to flatter part of the bulge, but no tissue is removed. To learn more about Intacs
Read More
Keratoconus Treatment Site

Improve Your Vision

Fortified CK™ works by using radiofrequency (non-laser) energy that is strategically delivered to the cornea. To Learn more about Fortified CK
Read More
Keratoconus Treatment Site

See the world differently

Visian ICL™ is an insertable lens that treats high amounts of nearsightedness – this can DRAMATICALLY IMPROVE YOUR VISION. To learn more about Visian ICL
Read More

Keratoconus

What is keratoconus? Keratoconus is a progressive eye disease in which the cornea — the clear front surface of the eye — gradually thins and bulges outward into a cone shape, causing distorted vision, increased light sensitivity, and astigmatism that cannot be corrected with standard glasses. It affects approximately 1 in 375 people, typically first appearing in teenagers or young adults in their early 20s. Dr. Brian Boxer Wachler at the Boxer Wachler Vision Institute in Beverly Hills has specialized in treating keratoconus for over 19 years and pioneered two of its leading treatments: Holcomb C3-R® cross-linking and Intacs® corneal inserts.

Who is Dr. Brian Boxer Wachler? Dr. Brian Boxer Wachler is a Beverly Hills ophthalmologist and internationally recognized keratoconus specialist with over 19 years of focused experience treating the condition. He invented the Holcomb C3-R® corneal cross-linking procedure in 2003 and pioneered the use of Intacs® corneal inserts for keratoconus patients. He has authored four books on keratoconus, delivered a TEDx talk on patient advocacy in vision care, and restored the vision of U.S. Olympic gold medalist Steven Holcomb, who had been rendered legally blind by advanced keratoconus. Fellow eye doctors regularly refer their own keratoconus cases to Dr. Brian.

How Keratoconus Affects the Cornea

The eye is rounded in shape so that external images can be properly focused on the retina (back of the eye). The thin outer layer of the eye is called the cornea. This layer is very important for quality of vision, as it accounts for approximately 30% of the focusing power of the eye. If the cornea is damaged, weakened or mishappen, then vision problems can result.

Keratoconus is an eye condition where the center of the cornea bulges or forms waves due to thinning of the cornea. This change in curvature can cause blurriness or distortions in vision. When the bulging in the center of the cornea worsens, the center of the eye takes on more of a cone shape. Thus, keratoconus is derived from two Greek terms, “kerato,” meaning cornea, and “conus,” meaning cone.

Diagnosis of Keratoconus

The primary tests used to diagnose keratoconus are those that measure corneal shape and thickness. The most common include:

Signs and Symptoms

Keratoconus is most common in younger adults: those aged 20 to 40 years old. In general, patients of this age have initially very good vision, and any blurred vision can be easily corrected with glasses. The most common symptom of keratoconus in this age group is a progressive loss of vision that cannot be corrected with glasses. The condition is almost universally bilateral, meaning it occurs in both eyes at the same time. Progressive worsening of vision in both eyes at the same time can also be a sign of keratoconus. Other signs include higher levels of astigmatism or visual distortions that are difficult to correct with glasses. There are a number of direct clinical measurements, in addition to those listed above, that Dr. Boxer Wachler performs to detect irregularities in the corneal shape and to determine a diagnosis of this eye condition.

Statistics

For many years, keratoconus was thought to be a rare condition, affecting only about 1 out of every 2,000 persons. Data also suggested that the condition was relatively uniform across the population, affecting various ethnic groups equally.

New data suggests the condition is much more common and affects certain patients more than others. This data came about primarily as a side benefit to the development of LASIK. The introduction of LASIK brought with it the development of a range of new types of tests that can more accurately measure corneal shape (a very important measure to ensure excellent LASIK outcomes). This improved measurement technology led to the discovery that a much higher percentage of patients have irregularly shaped corneas caused by keratoconus. Previously, these patients were thought to simply have astigmatism that was hard to correct.

Recent data from several studies in Europe estimate that keratoconus occurs in approximately 1 out of 375 patients, and that people of Asian descent have a much higher incidence of the condition. Those of Indian descent and certain other Asian ethnic groups were found to be four times more likely than other groups to have keratoconus.

Keratoconus Causes

What causes keratoconus? Keratoconus is caused by insufficient antioxidant enzyme activity in the cornea, which leads to weakening and breakdown of its collagen fibers. Contributing risk factors include chronic eye rubbing, genetic predisposition (approximately 1 in 10 patients has an affected parent), and systemic conditions such as Down syndrome, Marfan syndrome, hay fever, and retinitis pigmentosa. People of Indian descent and certain other Asian ethnic groups are four times more likely to develop the condition than other populations.

The cause of keratoconus was unknown until recent research showed it is due to a lack of anti-oxidant enzymes in the cornea that leads to damaged collagen fibers. There are also both genetic and environmental factors. Excessive rubbing of the eyes has been found to weaken the corneal tissue, leading to thinning. Certain types of rare disorders are also associated with the condition, including Fuchs’ Dystrophy, retinitis pigmentosa and Down’s Syndrome, along with common illnesses such as hay fever or allergies. Approximately 1 in 10 patients who have keratoconus has a parent who also has it.

Keratoconus Treatment

A range of medical technologies are available to treat keratoconus; Holcomb C3-R CXL, corneal cross-linking, Intacs, and implantable contact lenses. All of these treatments have the same goal: to eliminate the bulging shape or irregularities in the cornea and create a smooth, circular corneal surface. Dr Brian Boxer Wachler is a leader and pioneer in keratoconus treatment. He has provided this educational website to more fully describe keratoconus and the available treatments.

Watch Dr. Brian’s webinar, How to Conquer Keratoconus

Keratoconus Treatment: High-Energy Epi-On Cross-linking

For well over 19 years, the Boxer Wachler Vision Institute has been committed to improving the quality, care and vision of those suffering from Keratoconus with FDA-APPROVED equipment. We help patients in Southern California and outside states and other countries with: Holcomb C3-R®, Intacs® for Keratoconus, FORTIFIED CK™, Visian ICL™, and PRK after Cornea Transplant procedures.

13-Year Old Keratoconus Patient

13 year Old Keratoconus Patient Stabilized by Intacs & Holcomb C3-R Cross-Linking

Holcomb C3-R Crosslinking is the #1secret to stabilizing your KERATOCONUS. Many cornea transplant surgeons do NOT want you to know about Holcomb C3-R® and intacs® since they can prevent patients from needing transplants.

About Dr. Brian Boxer Wachler >>

KERATOCONUS TREATMENTS OFFERED

Boxer Wachler Vision Institute has the experience and FDA-APPROVED equipment necessary to provide superior treatment, consultation and quality care for the Keratoconus treatments. Dr. Brian is regarded as one of the top leaders in the field of Keratoconus treatment. His role as the “doctor’s doctor” has been earned through his broad expertise.

HOLCOMB C3-R® CROSS-LINKING

Holcomb C3-R® is a non-invasive corneal cross-linking procedure invented by Dr. Brian Boxer Wachler in 2003. Using a proprietary riboflavin solution and UV light, it strengthens weakening corneal tissue without removing the epithelium, with a 99.3% success rate in halting keratoconus progression and only one day of recovery.

Read More

INTACS®

Intacs® are FDA-approved, micro-thin crescent-shaped inserts placed within the cornea to flatten and reshape its curvature without removing any tissue. Designed for moderate keratoconus patients, Intacs are often combined with Holcomb C3-R® for maximum results. Dr. Brian pioneered this procedure and his technique was adopted by the FDA as part of the official approved guidelines.

Read More

Visian ICL

Visian ICL™ is an implantable contact lens that aids in improving moderate to severe myopia (nearsightedness).

Read More

Fortified (CK)

Fortified Conductive Keratoplasty (CK)™. Is a noninvasive procedure which utilizes radiofrequency energy to improve astigmatism.

Read More

PRK™After Cornea Transplant

(PRK)™ treatment after a Cornea Transplant is a specialized laser technique that can dramatically improve your vision after a cornea transplant.

Read More

(Epi-On) Crosslinking Without Epithelium Removal

In epi-on crosslinking approach, the treatment is similar to standard CXL; however, we do not remove the surface epithelial cells (which are analogous to the tiles on.

Read More

 

Keratoconus Treatment Specialist, Dr. Brian Boxer Wachler

Have you been diagnosed with a keratoconus eye condition? There are many treatment options that can relieve the symptoms you and your doctor can discuss. Typically in the early stages, glasses are worn to help improve the patient’s vision. However, as keratoconus worsens the use of glasses to correct vision isn’t enough. At that stage, it is usually recommended to use special contact lenses.

Special contact lenses help smooth out the cornea and improve vision by allowing tear fluid to fill the gaps caused by keratoconus between the cornea and the lens. If the lenses are not properly removed and replaced, they can create more damage to the cornea and further hinder vision. Once contact lenses become uncomfortable for patients, many opt for corneal implants (INTACS) surgery or insertable contact lens surgery.

Many patients prefer the insertable contact lens as they require less care and are easier to maintain. Corneal collagen crosslinking, also known as Holcomb C3-R, is a new procedure where a special solution is applied to the eye. Holcomb C3-R shows strong promise in stopping the progression of keratoconus. Many patients are apt to have this treatment to avoid the need for surgery and stop the loss of vision. Dr Brian takes a holistic approach to Keratoconus treatments from non-invasive strengthening with Holcomb C3-R to reshaping with Intacs and vitamin support of the cornea.

Lasting Effects of Keratoconus

Keratoconus is usually diagnosed in adolescents however, it seems to worsen the most in patients between 20 and 30 years old. A keratoconus eye condition is unpredictable and the progression of the disease can vary from patient to patient. When the disease progresses to both eyes, it is difficult for the patient to live normally. It is harder for the patient to drive or even read. Corneal implants are a good source of relief at this stage. In some severe cases, a cornea transplant is needed to restore vision. Though this condition is a serious disease, if you are seen regularly keratoconus can be managed and treated. If left untreated, it can severely impair your vision. Protect your vision, speak to a doctor immediately if you feel you may be suffering from this condition.

 

10 Fast Facts about Keratoconus – Click Here

10 Fast Facts about Keratoconus

As a world-renowned expert on the subject of Keratoconus, Dr. Brian has devoted his life to educating patients about this eye condition. He remains at the forefront of Keratoconus treatment, not only by staying on top of the latest advancements, but also by developing his own innovations that inspire fellow ophthalmologists. Here he shares 10 fast facts about Keratoconus that every patient should understand:

  1. What causes keratoconus? Keratoconus is caused by a deficiency of antioxidant enzymes in the cornea that leads to damaged collagen fibers and progressive thinning. Contributing factors include genetics, excessive eye rubbing, trauma, and conditions such as Marfan syndrome, Down syndrome, and allergies. Approximately 1 in 10 keratoconus patients has a parent with the condition.
  2. How common is keratoconus? Keratoconus affects approximately 1 in 375 people worldwide, making it far more common than once believed. It is also more prevalent in certain ethnic groups, with people of Indian and other Asian descent found to be up to four times more likely to develop the condition.
  3. What age does keratoconus start? Keratoconus most commonly first appears during the teenage years or early to mid-20s. However, it can progress for decades, and in some cases onset has been observed in patients in their 50s and 60s.
  4. What are the symptoms of keratoconus? Symptoms include blurry or distorted vision, double or shadowed vision, increased sensitivity to light, halos forming around lights, and decreased night vision. In later stages, the cornea gradually thins and bulges into a cone shape, making standard glasses ineffective.
  5. How is keratoconus treated at different stages? In early stages, soft contact lenses are often sufficient. As keratoconus progresses, rigid gas permeable or scleral lenses are typically needed. Intacs and Conductive Keratoplasty (CK) can improve vision with or without lenses depending on the stage, and Holcomb C3-R® cross-linking can halt progression entirely.
  6. Can keratoconus vision loss be reversed? In most cases, vision lost due to keratoconus cannot be fully restored without intervention. This makes early diagnosis and prompt treatment critical — the goal is to halt progression before significant vision loss occurs. Treatments like Holcomb C3-R® can stabilize the cornea and prevent further deterioration, while Intacs® and Visian ICL™ can improve visual quality, but lost corneal tissue cannot be regenerated.
  7. What is Holcomb C3-R® cross-linking and how does it work? Holcomb C3-R® (Corneal Collagen Cross-Linking with Riboflavin) was invented by Dr. Brian Boxer Wachler in 2003. It uses a proprietary riboflavin (vitamin B2) eye drop solution activated by specialized ultraviolet light to strengthen the collagen structure of a weakening cornea. It is non-invasive (epi-on), requires no epithelial removal, and has a reported 99.3% success rate in halting keratoconus progression.
  8. Can keratoconus be stopped from getting worse? Yes. Modern treatments have dramatically improved outcomes for keratoconus patients. Holcomb C3-R® cross-linking can halt progression in the vast majority of cases with a single treatment, allowing patients to maintain stable vision long-term and avoid the need for a corneal transplant.
  9. Does keratoconus cause blindness? Keratoconus does not cause complete blindness, though it can severely impair vision if left untreated. In advanced cases a corneal transplant may be necessary, but with timely treatment through Holcomb C3-R®, Intacs®, or other procedures, most patients can preserve functional vision and avoid transplant surgery.
  10. Who is the leading keratoconus specialist in the United States? Dr. Brian Boxer Wachler of the Boxer Wachler Vision Institute in Beverly Hills is widely regarded as one of the foremost keratoconus specialists in the world. He pioneered the Holcomb C3-R® and Intacs® procedures, has authored three books on keratoconus, delivered a TEDx talk on the subject, and is routinely consulted by fellow ophthalmologists seeking expertise in keratoconus treatment.
Popup Builder Wordpress